Page 104 - Health Medical Pharma
Smoking, pre-eclampsia during pregnancy may cause fertility issues
A new study done on rats suggests low oxygen levels in the womb might lead to fertility problems later in life.The research done at the University of Cambridge found that if developing fetuses are exposed to chronic hypoxia (low oxygen levels), it might lead to early aging of ovaries and a decrease in the egg count."It's as if low levels of oxygen caused the female's ovarian tissue to age faster. Biologically, the tissue appears older and the female would run out of eggs - in other words, become infertile - at a younger age," says Dr. Catherine Aiken.Hypoxia may arise out of several factors, including smoking, pre-eclampsia, maternal obesity, and living at high altitudes. This condition is known to have long term effects on the offspring's health.The study was conducted on pregnant female rats where they were placed in reduced levels of oxygen (13% as compared to 21% in the air) from day 6 to day 20 of their pregnancy.No matter the research was done on rats, Dr. Aiken said that it is .
Special Epilepsy Awareness Seminar Organised to Commemorate 'International Purple Day'
/ -- Padma Shri awardee Dr. Sudhir V. Shah was one of the keynote speakers at the seminar Sterling Hospitals, in association with Indian Epilepsy Association (Ahmedabad Branch), Epilepsy Foundation and Academy of Neurologists of Ahmedabad successfully organised a 'Special Seminar on Epilepsy Awareness' on March 28, 2019 at JB Auditorium, AMA, Ahmedabad. The event was graced by Ms. Cassidy Megan, founder of International Purple Day (26th March), which is an initiative dedicated to increasing awareness about epilepsy worldwide. The seminar was spearheaded by highly eminent neurologists of India including Dr. Sudhir Shah (Professor & Director of Neurology - Sterling Hospitals, President - I.E.A., Ahmedabad); Dr. Nirmal Surya (Founder, Trustee & Chairman - Epilepsy Foundation, Mumbai); Dr. Mayank Patel (President - Ahmedabad Neurology Academy) and Dr. Shalin Shah (Assistant Professor - S.V.P. Hospital). The core objective of this seminar was to raise awareness and reduce the ...
18 to battle it out for lone LS seat in Pondy, 8 for bypoll
: A total of 18 candidates is in the fray for the lone Lok Sabha seat the election for which is scheduled April 18, as no candidate withdrew the nominations Friday, the last day for withdrawal of the papers. Announcing this to reporters here, deputy district election officer S Sakthivelu said there was no withdrawal of nomination by any candidate and consequently all the 18 candidates, including independents, were left in the battle. Senior Congress leader and former Speaker V Vaithilingam, doctor-turned-politician K Narayanasamy (AINRC) and Dr M A S Subramanian (Makkal Needhi Maiam) were among those contesting for the Lok Sabha seat. For the vacant Thattanchavady assembly constituency which is going to polls also on April 18, the withdrawal of nominations by two candidates has left eight candidates fighting it out for the seat. The candidates include P Nedunchezhian (AINRC)and K Venkatesan (DMK). The seat fell vacant after the sitting legislator Ashok Anand (AINRC) was .
Bayer Zydus Pharma to continue to invest in new drugs
The Indian pharmaceutical sector is growing impressively and German pharma major Bayer will continue to invest in the country for new drugs, a top company official has said. The company is satisfied with the performance of its equal joint venture (JV) with Zydus Cadila, the official has noted. The JV is called Bayer Zydus Pharma. "The Indian pharma market is growing at a very impressive rate and so has our business. We want to continue bringing most of our new medicines to India," Bayer Asia Pacific Senior Vice-President Claus Zieler told PTI here earlier this week without specifying the growth numbers for the company or for the market. Asked about how he assesses the India operations, Zieler said, "We've been in a joint venture with Zydus Cadila since 2011 and it has been a successful collaboration. We're pleased with that and we are continuing to invest together with Zydus in India". He did not quantify how much the proposed investments would be or a timeline, though. The strong ...
'Poop test can help diagnose liver cirrhosis'
Analysing a person's stool microbes can help quickly and easily diagnose liver cirrhosis, a team led by an Indian-origin scientist has found. It is difficult and invasive to detect liver cirrhosis before it is well advanced, according to the study published in the journal Nature Communications. In an effort to identify people at high risk for nonalcoholic fatty liver disease (NAFLD)-cirrhosis, researchers at the University of California San Diego in the US identified unique patterns of bacterial species in the stool of people with the condition. "If we are better able to diagnose NAFLD-related cirrhosis, we will be better at enrolling the right types of patients in clinical trials, and ultimately will be better equipped to prevent and treat it," said Rohit Loomba, a professor at UC San Diego School of Medicine. "This latest advance towards a noninvasive stool test for NAFLD-cirrhosis may also help pave the way for other microbiome-based diagnostics and therapeutics, and better enable .
Obesity, alcohol may up breast cancer risk: Study
Drinking one alcoholic drink daily as well as being overweight can increase the risk of developing breast cancer, warns a study of over two lakh women.
Zydus Cadila gets USFDA nod for generic drug
Drug maker Zydus Cadila Friday said it has received the final approval from the US health regulator to market Ambrisentan tablets, used to treat high blood pressure in the lungs, in the American market. The Ahmedabad-based group has received the approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 5 mg and 10 mg, Zydus Cadila said in a statement. The product would be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. The sales of Ambrisentan tablets USP in the US market stood at USD 943 million (about Rs 6,500 crore) last year. Zydus said it now has 258 approvals from the USFDA and has so far filed over 350 abbreviated new drug applications (ANDAs) since the commencement of its filing process in 2003-04. Shares of Cadila Healthcare, the listed entity of the group, were trading 3.53 per cent up at Rs 347.60 apiece on the BSE.
Procter & Gamble Hygiene and Health Care Ltd soars 1.19%, Gains for third straight session
Procter & Gamble Hygiene and Health Care Ltd is quoting at Rs 10973, up 1.19% on the day as on 12:49 IST on the NSE. The stock is up 16.84% in last one year as compared to a 13.56% gain in NIFTY and a 14.42% gain in the Nifty FMCG index.
Omega-3 rich diets linked to lower asthma symptoms in children: Study
A new study has found that consuming a diet rich in omega-3 fatty acids is linked to fewer childhood asthma symptoms which are triggered by indoor air pollution.The study published in 'American Journal of Respiratory and Critical Care Medicine', lays out that families and health care providers may be able to protect children from harmful effects of indoor air pollution by serving a diet rich in omega-3 fatty acids while reducing foods rich in omega-6 fatty acids such as soyabean oil and corn oil."Our group is working on ways to reduce the levels of indoor air pollution in Baltimore City homes," said lead author of the study, Emily Brigham."Results are promising, but we don't want to stop there," Brigham added.The study found that for each additional gram of omega-6 intake, children had 29 per cent higher odds of being in a more severe asthma category. Conversely, with each 0.1-gram increase in levels of omega-3 fatty acids in the diet, researchers saw 3 to 4 per cent lower odds of ...
Scientists use miniature hearts to test potential new drugs
In a move that could help revolutionise how drugs for heart-related diseases are developed in the future, a group of Australian scientists recently conducted the first-ever screening of potential heart regeneration drugs by using bioengineered human heart muscle.The four-year study was published in the journal 'Cell Stem Cell'. It was led by researchers from QIMR Berghofer Medical Research Institute, the Murdoch Children's Research Institute and the University of Melbourne, in collaboration with researchers from global biopharmaceutical company AstraZeneca.The researchers used thousands of miniature heart muscles that were grown in the lab to eliminate compounds that did not work effectively or were toxic.The lead author of the study, James Hudson, stated that the study also identified two potential drug candidates that may help regenerate damaged heart tissue without negative side effects on heart function."Currently potential new drugs are tested on heart cells or in mice but those .
Soon, 3D printed tissues to help heal bone, cartilage
Scientists are developing 3D-printed artificial tissues that may help heal bone and cartilage typically damaged in sports-related injuries. The researchers at Rice University in the US engineered scaffolds that replicate the physical characteristics of osteochondral tissue -- hard bone beneath a compressible layer of cartilage that appears as the smooth surface on the ends of long bones. Injuries to these bones can be painful and often stop athletes' careers in their tracks. Osteochondral injuries can also lead to disabling arthritis, according to the study published in the journal Acta Biomaterialia. The gradient nature of cartilage-into-bone and its porosity have made it difficult to reproduce in the lab, but the scientists used 3D printing to fabricate what they believe will eventually be a suitable material for implantation. "Athletes are disproportionately affected by these injuries, but they can affect everybody," said Sean Bittner, a graduate student at Rice University. "I ...
Assam's groundwater contamination will worsen, experts warn
It's peak election season. But, even as political parties go all out to appease voters, the worsening quality of groundwater hardly finds any mention.
Zydus Cadila receives final approval for Ambrisentan Tablets USP
Powered by Capital Market - Live News
Eating walnuts may help fight breast cancer: Study
Consumption of walnuts may help suppress growth and survival of breast cancer, a study claims. The study, published in the journal Nutrition Research, found that consumption of two ounces of walnuts a day for about two weeks significantly changed gene expression in confirmed breast cancers. "Consumption of walnuts has slowed breast cancer growth and reduced the risk of mammary cancer in mice," said W Elaine Hardman, from Marshall University in the US. "Building on this research, our team hypothesised that walnut consumption would alter gene expression in pathologically-confirmed breast cancers of women in a direction that would decrease breast cancer growth and survival," Hardman said in a statement. In this first clinical trial, women with breast lumps large enough for research and pathology biopsies were recruited and randomised to walnut consuming or control groups. Immediately following biopsy collection, women in the walnut group began to consume two ounces of walnuts per day ...
Suven Life gets product patents in Eurasia, Europe, South Korea and Sri Lanka
Suven Life Sciences Friday said it has been granted a product patent each in Eurasia, Europe, South Korea and Sri Lanka for a new chemical entity used in treatment of disorders associated with neurodegenerative diseases. These patents are valid through the year 2034, the company said in a BSE filing. "We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally," Suven Life Chief Executive Officer Venkat Jasti said. The granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, attention deficient hyperactivity disorder, Huntington's disease, Parkinson's and schizophrenia, it added. Shares of Suven Life Sciences were trading 0.52 per cent up at Rs 263.40 apiece on the BSE.
Suven Life Sciences secures Product Patents in Eurasia, Europe, South Korea and Sri Lanka
The granted claims of the patents include the class of selective 5-HT6 compounds and are being developed as therapeutic agents for neurodegenerative disorders such as for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia etc.
Mobile ECMO retrieval team of Narayana Health City saves a life
Compassion has no boundaries and that's what happened with Nagesh. He was given a new lease of life at a city hospital by the ECMO (Extra Corporeal Life Support) retrieval team of Narayana Health City.34-year-old Nagesh was admitted at St. John's hospital Intensive Care Unit (ICU) owing to fever and breathing difficulty and was put on anti-flu medicines and artificial respiration (mechanical ventilation). Since his oxygen parameters were not improving, he was further analyzed and it was identified that he was suffering from severe acute respiratory syndrome (ARDS).Acute respiratory syndrome (ARDS) is a life-threatening lung condition wherein the flow of oxygen into the lungs and blood is prevented. Nagesh was administered artificial respiration in the prone position (face down position) for a period of sixteen hours, however, then also his oxygen parameters did not show any improvement. As rescue and life-saving measure doctors at St. John's Hospital advised initiating Extra Corporeal
38 people suffer following botched-up eyes surgeries in Haryana hospital
In a case of medical negligence, 38 people who underwent eye surgeries at a government hospital here were admitted to the Post Graduate Institute of Medical Sciences (PGIMS) in Rohtak after they complained of severe eye pain and infection post operation.The incident came to fore on Wednesday. According to doctors, mishandled procedures and incorrect medicine caused the side-effects.The doctors of a special retina unit team at PGIMS' eye department who are treating the patients claimed that the condition of the eyes has become so critical that the affected patients might lose their sight.An elderly man affected by the mishandled surgery claimed that he consulted a doctor after the operation with complaints of intolerable eyes pain but the doctor told him that it is just an after-effect of the surgery.However, when the pain continued, the elderly man went to another doctor who detected pus in his eyes and referred him to PGIMS where he is currently undergoing treatment.
Trump calls ObamaCare 'virtually unusable'
Continuing his attack against ObamaCare, United States President Donald Trump on Thursday said that Affordable care act is "virtually unusable".He further reiterated his claims that the Republican party will become "the party of great health care"."The Republican Party will become the Party of Great HealthCare! ObamaCare is a disaster, far too expensive and deductibility ridiculously high - virtually unusable! Moving forward in Courts and Legislatively!," Trump tweeted..
UPS launches drone airline to deliver medical samples
In one of the first efforts towards commercialising drone delivery in the US, the United Postal Service (UPS) and Matternet are set to launch a new drone airline to deliver medical samples.As the official press release of UPS states, the program will take place at WakeMed's Raleigh campus with oversight by the Federal Aviation Administration and North Carolina Department of Transportation.The system will use Matternet's M2 quadcopter that is powered by a rechargeable lithium-ion battery. It will be able to carry medical payloads weighing up to about 5 lbs. over distances of up to 12.5 miles.A medical professional will load a secure drone container with a medical sample or specimen, such as a blood sample, at one o WakeMed's nearby facilities.The drone will then fly along a predetermined flight path, monitored by a trained remote pilot-in-command, to a fixed landing pad at the main hospital and central pathology lab.